Results 71 to 80 of about 1,073 (146)

Assessing Graves' ophthalmopathy-specific quality of life in Korean patients [PDF]

open access: yes, 2012
AIM: To investigate the clinical significance of Grave's ophthalmopathy-specific quality of life (GO-QOL) in Korean patients. METHODS: A cross-sectional study was conducted at the Department of Ophthalmology, Yonsei University College of Medicine ...
이상열, 윤진숙
core  

Graves' ophthalmopathy: interdisciplinary approach

open access: yesКлиническая и экспериментальная тиреоидология, 2010
Graves' ophthalmopathy constitutes a major therapeutic challenge, so specialists of various disci-plines have to combine their forces. According to the last consensus of EUGOGO (European Group On Graves' Orbitopathy) the treatment of choice for Graves ...

doaj   +1 more source

Graves ophthalmopathy a neglected comorbidity of graves’ disease; a detailed investigation and management of sixty-eight patients in a tertiary healthcare center

open access: yesBMC Endocrine Disorders
Purpose To compare the measurements of macular thickness, intraocular pressure and RNFL and hormone parameters before and after antithyroid therapy in patients with Graves’ Ophthalmopathy (GO).
Gamze Akkus   +6 more
doaj   +1 more source

Morbidité et mortalité du protocole EUGOGO dans le cadre de la prise en charge de l'orbitopathie Basedowienne:thèse présentée pour le diplôme d'État de docteur en médecine, diplôme d'État, mention D.E.S endocrinologie, diabétologie et nutrition

open access: yes, 2022
Médecine (endocrinologie, diabétologie et nutrition)L'orbitopathie est la manifestation extra-thyroïdienne la plus fréquente de la maladie de Basedow, engageant le pronostic visuel. La corticothérapie lV est recommandée dans les formes modérées à sévères
Herfeld, Grégoire
core  

The relationship between cholesterol levels and thyroid eye disease

open access: yesEuropean Thyroid Journal
Background: Thyroid eye disease (TED) is the most prevalent extrathyroidal manifestation of Graves’ disease (GD). Emerging evidence suggests a relationship between elevated total and low-density lipoprotein (LDL) cholesterol levels and TED.
Caroline Cardo   +5 more
doaj   +1 more source

Combination Therapy of Intravenous Steroids and Orbital Irradiation is More Effective Than Intravenous Steroids Alone in Patients with Graves’ Orbitopathy

open access: yes, 2017
The aim of this study was to evaluate and compare the efficacy of intravenous (iv) glucocorticoids (GCs) with and without orbital radiotherapy (ORT) in a retrospective analysis of patients with active, moderate-to-severe Graves’ orbitopathy (GO).
Anja Eckstein   +5 more
core   +1 more source

Awareness of EUGOGO guidelines and attitudes regarding smoking in Graves' orbithopathy in Croatia

open access: yesTaiwan Journal of Ophthalmology, 2022
Baretic Maja   +5 more
doaj   +1 more source

Risk Factors for Ocular Surface Irritation Symptoms in Inactive Mild and Moderate-to-Severe Graves’ Orbitopathy

open access: yesOphthalmology and Therapy
Introduction This study aims to analyze risk factors for ocular surface irritation symptoms in patients with non-corneal-damage inactive mild and moderate-to-severe Graves’ orbitopathy (GO). Methods This retrospective study enrolled 307 patients with non-
Yun Yu   +6 more
doaj   +1 more source

Multidimensional predictive model for assessing clinical activity in thyroid eye disease

open access: yesFrontiers in Medicine
ObjectiveThyroid eye disease (TED) is an autoimmune disorder with complex inflammatory activity that remains challenging to assess accurately.
Yang Li   +22 more
doaj   +1 more source

Determinants of clinical outcome in patients with moderate/severe Graves' orbitopathy undergoing treatment with parenteral glucocorticoids: a retrospective study

open access: yesFrontiers in Endocrinology
BackgroundGraves' orbitopathy (GO) occurs in approximately 25-40% of patients with Graves' disease (GD). High levels of anti-thyrotropin receptor antibodies (TRAbs), smoking habit, sex, older age, longer duration and amount of hyperthyroidism or ...
Rosario Le Moli   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy